During the past decade, Ina Central Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ina Central Hospital" are "Kidney Disease, Chronic" (1 trials), "Secondary Prevention" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Ina Central Hospital" in a lesser frequency.

Most popular intervention types in "Ina Central Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "BI 690517" (1 trials), "Empagliflozin" (1 trials), "Placebo to BI 690517" (1 trials) and "Placebo to empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ina Central Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ina Central Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ina Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ina Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".